BOCA RATON, Fla.--(BUSINESS WIRE)--Nutra Pharma Corp. (OTCBB:NPHC), a biotechnology company that is developing drugs for HIV and Multiple Sclerosis (MS) has announced today that its holding, ReceptoPharm, has been invited to present its recent analgesic research on RPI-78M at the International Conference on Neurotoxins (ICoN) in Hollywood, Florida.
